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Bergen, NorwayABSTRACT Human tyrosine hydroxylase activity is regulated by phosphorylation of its N-terminus and by an interaction with
the modulator 14-3-3 proteins. We investigated the binding of singly or doubly phosphorylated and thiophosphorylated peptides,
comprising the first 50 amino acids of human tyrosine hydroxylase, isoform 1 (hTH1), that contain the critical interaction domain,
to 14-3-3z, by 31P NMR. Single phosphorylation at S19 generates a high affinity 14-3-3z binding epitope, whereas singly S40-
phosphorylated peptide interacts with 14-3-3z one order-of-magnitude weaker than the S19-phosphorylated peptide. Analysis of
the binding data revealed that the 14-3-3z dimer and the S19- and S40-doubly phosphorylated peptide interact in multiple ways,
with three major complexes formed: 1), a single peptide bound to a 14-3-3z dimer via the S19 phosphate with the S40 phosphate
occupying the other binding site; 2), a single peptide bound to a 14-3-3z dimer via the S19 phosphorous with the S40 free in
solution; or 3), a 14-3-3z dimer with two peptides bound via the S19 phosphorous to each binding site. Our system and data
provide information as to the possible mechanisms by which 14-3-3 can engage binding partners that possess two phosphor-
ylation sites on flexible tails. Whether these will be realized in any particular interacting pair will naturally depend on the details of
each system.INTRODUCTIONMembers of the 14-3-3 protein family are important modu-
lators of several key signaling pathways that regulate critical
biological activities, including progression through the cell
cycle, growth, proliferation, and apoptosis (1–3). Extensive
proteomics studies have revealed that the 14-3-3 family tar-
gets>200 distinct partners, ~0.6% of the entire cellular pro-
teome (4,5).
In humans, seven different 14-3-3 isoforms (b, g, ε, h, s,
t, and z) are found, each encoded by a distinct gene, that
function as homo- or heterodimers of ~30-kDa proteins
(6,7). Crystal structures of all seven homodimeric mamma-
lian proteins are available. The fold of the monomeric unit
contains nine a-helices, arranged in an antiparallel fashion.
Within the dimeric structure, two amphipathic grooves, one
per monomer, constitute the binding pockets in which
the conserved KRRY residues-Lys49, Arg56, Arg127, and
Tyr128 in 14-3-3z-are positioned for the recognition of
a phosphorylated serine or threonine target (8). Three
different phosphoserine (pS)- or phosphothreonine-contain-
ing sequence motifs can be recognized by 14-3-3 proteins:
RSXp(S/T)XP (motif I), RXXXp(S/T)XP (motif II), and a
carboxyl-terminal p(S/T)XCOOH motif (motif III), where
X is a nonproline amino acid (9–11). Some 14-3-3 family
members have also been reported to bind nonphosphory-Submitted June 30, 2014, and accepted for publication August 28, 2014.
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the above canonical sequences (6,11).
Tyrosine hydroxylase (TH) and tryptophan hydroxylase
were the first proteins that were identified as binding partners
for 14-3-3 proteins (12). TH catalyzes the tetrahydrobiop-
terin-dependent hydroxylation of L-tyrosine to L-3,4-dihy-
droxyphenylalanine, which is the rate-limiting step in the
biosynthesis of dopamine and other catecholamines (13).
In humans, several isoforms of TH are expressed, with iso-
form 1 (hTH1; 497 residues, NP-000351.2) being the best
characterized (14–16). hTH1 can be phosphorylated at T8
and/or three serine residues (S19, S31, and S40) by several
protein kinases (17) on its highly dynamic 50-residue N-ter-
minal region that precedes the regulatory ACT domain, char-
acteristic of the aromatic amino-acid hydroxylase family.
14-3-3z and other isoforms have been reported to bind
to S19 phosphorylated TH (18–20). Although not strictly
exhibiting the canonical binding motifs, recent crystallo-
graphic analysis of the complex between hTH1 S19-phos-
phorylated N-terminal peptide (1–43 residues) and 14-3-3g
revealed that the phosphate interacts with the KRRY motif
in the 14-3-3g binding grove, and the region surrounding
S19 engages in similar interactions as seen for peptides con-
taining canonical motifs I and II (21). In addition, phosphor-
ylation of hTH1 on S40 stimulates TH activity (17), and
induces binding to the yeast 14-3-3 proteins BMH1 and
BMH2 and to sheep brain 14-3-3 proteins, but not to 14-3-
3z (18,19). On the other hand, 14-3-3z has been reportedhttp://dx.doi.org/10.1016/j.bpj.2014.08.039
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(18). In a recent study (22) we have shown that the doubly
phosphorylated hTH1 binds 14-3-3g with similar stoichiom-
etry and affinity as the singly phosphorylated enzyme on
Ser19. However, 14-3-3g interfered with the phosphoryla-
tion of TH1-pS19 on Ser40, supporting that Ser40 becomes
inaccessible in the hTH1:14-3-3g complex, although Ser40
does not significantly contribute to the binding of 14-3-3g.
Therefore the question of whether S40 phosphorylated
hTH1 can be bound by 14-3-3 proteins has not been settled
unequivocally.
The 14-3-3 proteins are thought to function by inducing a
conformational change in the target proteins, thereby modu-
lating the target proteins’ activities. In this way, 14-3-3 fam-
ily members impart additional control onto key cellular
enzymes, in addition to common enzymatic control mecha-
nisms such as feedback loops or product inhibition. The
contemporary prevalent model for the binding of doubly
phosphorylated peptides by 14-3-3 suggests that one phos-
phorylated residue of the target protein engages 14-3-3 first,
linking the two proteins together, followed by binding of the
second phosphorylated residue, to effect the conformational
change (23). The notion that binding of 14-3-3 to two phos-
phorylation sites is required to induce the activity altering
conformational change, has led some authors to consider
14-3-3 as a binary computer (4,24).
We explored this model of 14-3-3 modulation using 31P
NMR in a simplified peptide system. We investigated the
binding of hTH1 peptides (region 1–50) with a single phos-
phorylation at S19 (pS19) or S40 (pS40) to 14-3-3z and deter-
mined individual binding affinities. We found that 14-3-3z
can interact with the hTH1 peptide through either phosphor-
ylated-S19 or -S40, although the binding affinity of 14-3-3z
for the pS40 peptide is significantly lower than that for the
pS19 peptide. Furthermore, binding of 14-3-3z to the doubly
phosphorylated hTH1 peptide exhibits a complex binding
profile involving three major complexes. Our results suggest
that when considering 14-3-3 interactions withmultiply phos-
phorylated targets in general, and hTH1 in particular, avidity
considerations should be taken into account.METHODS
Cloning, expression, and purification of hTH1
peptides and 14-3-3z
The coding region for residues 1–50 of human tyrosine hydroxylase
(hTH1–50) (Fig. 1 A) was inserted into a modified pET32a vector, in frame
with N-terminal thioredoxin and 6His tags, followed by a tobacco etch vi-
rus (TEV) cleavage site. A codon-optimized gene for 14-3-3z (GenScript,
Piscataway Township, NJ) was inserted into pET15b with Cys25 and
Cys189 codons converted to Ala using the QuikChange Site-Directed Muta-
genesis Kit (Stratagene, La Jolla, CA). The DNA sequence for all constructs
was confirmed by sequencing (Genewiz, South Plainfield, NJ).
Proteins were produced in Escherichia coli BL21(DE3) cells that were
grown at 37C in LB media to an OD600 of 0.8 and induced with 0.5 mM
IPTG for 18 h at 18C. Cells were harvested, resuspended in 50 mM TBSBiophysical Journal 107(9) 2185–2194(50 mM Tris, 150 mMNaCl, pH 8.0) buffer, and lysed with a microfluidizer
(Microfluidics, Westwood, MA). The cell lysate was clarified by centrifuga-
tion (21,000g for 60 min at 4C), and the supernatant was loaded onto a
HisTrap column (GE Healthcare, Piscataway, NJ). Proteins were eluted us-
ing a linear imidazole gradient (0.05–1 M in a total volume of 15 mL).
Fractions containing tagged hTH1 peptide were treated with TEV (1 mg/
20 mg of peptide) at 4C overnight, and applied to a Vydac reverse-phase
C4 column (Grace Davison Discovery Sciences, Deerfield, IL). hTH1–50
was eluted from the reverse phase column using a linear gradient of 10–
40% acetonitrile in 50 mL. Peptide-containing samples were further puri-
fied by gel filtration through a Superdex75 26/60 column (GE Healthcare)
equilibrated in 20 mM Tris buffer, pH 7.5. The Trp-containing three amino-
acid cloning artifact at the N-terminus of the hTH1–50 peptide (Fig. 1 A)
allowed for detection during purification and concentration determination
at 280 nm.
Fractions containing 14-3-3z were dialyzed into TBS buffer and treated
with TEVovernight. Undigested protein, 6His tag cleavage products, and
TEV protease were removed by passing the sample over the HisTrap col-
umn for a second time and the flow-through containing untagged 14-3-3z
was collected. The sample was further purified over anion exchange
(HiTrap Q HP; GE Healthcare) followed by gel filtration on a Superdex75
26/60 column (GE Healthcare), equilibrated in 20 mM sodium phosphate
buffer, pH 7.0.
The Cys25Ala/Cys189Ala 14-3-3z variant exhibited essentially the same
stability as wild-type 14-3-3z protein, as evidenced by identical differential
scanning calorimetry unfolding profiles.Phosphorylation of hTH1–50
The serine residue at position 40 of the hTH1–50 peptide was phosphory-
lated using the catalytic subunit of cAMP-dependent protein kinase A
(PKA; New England BioLabs, Ipswich, MA), whereas Ser19 was phosphor-
ylated using p38 regulated/activated protein kinase (PRAK; obtained from
the protein phosphorylation unit, University of Dundee, Dundee, Scotland).
For phosphorylation at S19, the reaction mixture, containing hTH1–50
S40A peptide in 50 mM Tris buffer, pH 7.5, 1 mM ATP, 10 mM MgCl2,
and PRAK kinase (50 mg for 10 mg of hTH1–50 S40A), was incubated
for three days at 30C. For phosphorylation at S40, hTH1–50 was incubated
with PKA (0.5 mg for 15 mg hTH1–50) in 50 mM Tris buffer, pH
7.5,10 mM MgCl2, 200 mM ATP at 30
C for 2 h. Reaction products were
purified by gel filtration using a Superdex30 16/60 column (GE Healthcare)
followed by anion exchange (HiTrap Q HP; GE Healthcare).
Doubly phosphorylated peptide was prepared using S40 phosphorylated
hTH1–50 peptide (pS40-hTH1–50) and PRAK kinase, as described above.
Approximately 70% of pS40-hTH1–50 was converted to the doubly phos-
phorylated product (pS19pS40-hTH1–50), which was purified as described
above. For thiophosphorylation, adenosine 50-[g-thio]triphosphate (ATPgS)
was added to the PKA reaction mixture, instead of ATP. In all cases, the cor-
rect masses and purity of the final products were verified by matrix-assisted
laser desorption/ionization-time of flight mass spectrometry.31P NMR titrations
All 31P NMR spectra were recorded at 37C on an AVANCE 600 MHz
NMR spectrometer equipped with a broadband frequency probe (Bruker,
Billerica, MA). Samples containing 14-3-3z and singly or doubly phosphor-
ylated hTH1–50 peptides were prepared in 20 mM sodium phosphate, pH
7.0, at a constant peptide concentration (0.83 or 0.71 mM) with molar ratios
of 14-3-3z to peptide of 0:1–8:1.Modeling of binding scenarios
Binding schemes for the different complexes between 14-3-3z and singly or
doubly phosphorylated peptides are presented in Fig. 1 C and Fig. 2 B,
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FIGURE 1 Binding of singly phosphorylated
hTH1–50 peptides to 14-3-3z. (A) Amino-acid
sequence of the hTH1–50 peptide with S19 and
S40 highlighted (boldface). (B) 31P spectra of
pS19-hTH1–50 at 0.83 mM peptide concentration
and molar ratios of 14-3-3z to peptide (r) 0.5:1
(black) and 1:1 (gray). (C) Schematic depiction
of pS19-hTH1–50 (denoted by 19–40) binding to
the 14-3-3z homodimer (free protein dimer is de-
picted by P[[, where Ø indicates an empty phos-
phoserine binding site). (Circled) Bound pS19
residues. (D) 31P spectra of pS40-hTH1–50 at
0.71 mM peptide concentration and molar ratios
(r) of 14-3-3z to peptide of 0:1 (blue), 0.5:1
(red), 1:1 (dark green), 2:1 (purple), 4:1 (orange),
and 8:1 (brown). (Inset) Chemical shift changes
upon 14-3-3z binding (Dd) are plotted as a function
of molar ratio (r). The curve obtained by fitting Dd
to the quadratic equation shown in Eq. 2 is shown.
To see this figure in color, go online.
Binding of Phospho-TH Peptides to 14-3-3 2187respectively. Equations for individual binding equilibria and equations
describing mass conservation are provided in Fig. S1 and Fig. S2 in the Sup-
porting Material. The equations were solved numerically using the software
MATLAB (The MathWorks, Natick, MA) and results yield populations of
the individual species as a function of the 14-3-3z to peptide molar ratios, r.
Three different sets of solutions were obtained, only one of which was physi-
callymeaningful given that populations cannot be negative for any r valueR0.RESULTS
Binding of singly phosphorylated hTH1 peptides
to 14-3-3z
Binding between 14-3-3z and the phosphorylated N-termi-
nus of hTH1 was probed by 31P NMR. hTH1 peptides, con-
taining the first 50 residues (hTH1–50), were prepared and
each serine in the peptide was phosphorylated individually,
generating pS19-hTH1–50 and pS40-hTH1–50. PKA selec-
tively and specifically phosphorylated only Ser40, but PRAKphosphorylated both Ser19 and Ser40 (J. Hritz and A.M. Gro-
nenborn, unpublished results). Therefore, we introduced the
S40A change, permitting the preparation of singly phos-
phorylated pS19-hTH1–50 peptide. Titration of 14-3-3z
into a solution containing pS19-hTH1–50 revealed the sys-
tem to be in slow exchange on the NMR chemical shift time-
scale. Thus, resonances for both free and the 14-3-3z-bound
peptide can be observed separately (Fig. 1 B), and the rela-
tive fractions of the free and bound peptide can be deter-
mined from resonance intensities (25,26). A dissociation
constant (Kd1) of 0.15 5 0.03 mM for the 14-3-3z/pS19-
hTH1–50 complex was derived, using
Kd1 ¼
½pS19free  14 3 3zfree
½pS19bound
¼ cpep  AðpS19
freeÞ  fr  AðpS19boundÞg
AðpS19boundÞ ; (1)Biophysical Journal 107(9) 2185–2194
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FIGURE 2 Binding of doubly phosphorylated
peptide to 14-3-3z. (A) 31P spectra of pS19pS40-
hTH1–50 at 0.83 mM and the molar ratio of 14-
3-3z to the peptide (r) was 0:1 (blue), 0.5:1 (red),
1:1 (dark green), 2:1 (purple), 3:1 (yellow), 4:1 (or-
ange), or 5:1 (light green). (B) Binding scheme of
pS19pS40-hTH1–50 (denoted by 19–40) with
respect to the 14-3-3z homodimer (P[[). Dissocia-
tion constants Kd1 and Kd2 correspond to the values
determined for the singly phosphorylated peptides.
(Blue arrows) Equilibria for which slow exchange
on the 31P chemical shift scale is observed; (red
arrows) equilibria for which fast exchange on the
31P chemical shift scale is observed. (Circled)
Bound phosphorous groups. Phosphorous groups
contributing intensity to the same peak in the
NMR spectra are shown in the same color. (C)
Equations governing the relative peak intensities
(denoted as ‘‘A’’), based on the scheme depicted
in panel B; each phosphopeptide contributes to
one or more of the five peaks. The specific phos-
phoserine that contributes to intensity of a partic-
ular peak is colored in the same color as in panel
B. (D) Populations of phosphoserine species that
contribute to the experimentally observed peak in-
tensities (x) for different 14-3-3z to peptide molar
ratios, r. (Continuous lines) For comparison, the
theoretically predicted populations, based on the
binding model in panel B using Kd1 ¼ 0.15 mM,
Kd2 ¼ 1.0 mM, and Keq ¼ 1.5, are plotted. To see
this figure in color, go online.
2188 Hritz et al.where cpep, A(pS19
free), and A(pS19bound) comprise the total
peptide concentration, and the free and bound fractions of
the pS19-hTH1–50 peptide, respectively, with r the molar
ratio of 14-3-3z to peptide. For both singly phosphorylated
peptides, dissociation constants are reported for the 14-3-3z
monomer, assuming that binding to a single site in the 14-3-
3z homodimer is not influenced by binding to the second
site.Biophysical Journal 107(9) 2185–2194To analyze our binding data, we generated a scheme for
the interaction between pS19-hTH1–50 and the 14-3-3z
dimer (Fig. 1 C). A pS19-hTH1–50 peptide (represented
by 19–40 in Fig. 1 C) can bind to the free 14-3-3z dimer
(depicted by P[[ in Fig. 1 C) at two different sites, with
the dissociation constant being one-half of the observed
Kd1; the binding of a second pS19-hTH1–50 peptide to
the 14-3-3z dimer in which one site is already occupied
Binding of Phospho-TH Peptides to 14-3-3 2189(depicted by P/1940 in Fig. 1 C) can only occur to the un-
occupied site, and dissociation from a doubly occupied
14-3-3z dimer (depicted by P19401940 in Fig. 1 C) can
occur from either site, resulting in 2*Kd1. The equa-
tions describing these two equilibria, taking mass conser-
vation of the peptide and 14-3-3z into account, are
presented in Fig. S1 in the Supporting Material. Based
on this model, in a 1:1 mixture of pS19-hTH1–50 and
14-3-3z (monomer concentration) with a Kd1 of
0.15 mM, 34.4% of the peptide would be in the free state,
22.6% of peptide in the P/1940 bound form, and 43% in
the P19401940 bound form.
In contrast to the result with the pS19 peptide, titration of
14-3-3z into a solution containing the pS40-hTH1–50 pep-
tide revealed fast exchange on the NMR chemical shift
scale, resulting in a single resonance at the weighted aver-
aged chemical shifts of both the free and bound resonances
(Fig. 1D). By fitting the chemical shift change (Dd) to Eq. 2,
a Kd2 value of 1.05 0.1 mM and a maximum chemical shift
difference between free and bound peptide (Ddmax) of 0.94
p.p.m. were determined for the binding of 14-3-3z to pS40-
hTH1–50:
Dd ¼ Ddmax
2cpep

Kd þ cpep þ rcpep

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Kd þ cpep þ rcpep
2  4c2pepr
q 
: (2)
These values allowed us to calculate the 31P bound chemical
boundshift, d(pS40 ), which was 3.26 p.p.m. (Fig. 1 D).
Interestingly, the bound 31P chemical shifts for both
singly phosphorylated hTH1–50 peptides are essentially
identical (3.26 p.p.m., Fig. 1, B and D), irrespective of
the different neighboring amino acids around the phosphor-
ylated Ser in the hTH1–50 peptide. This suggests that the
binding of the phosphorylated residues to the identical
binding pockets of 14-3-3z that are lined by residues
Lys49, Arg56, Arg127, and Tyr128 is the major determinant
of the chemical shift, irrespective of the local peptide
sequence. We speculate that the side chain of Tyr128 most
likely causes the upfield shift of the pS19 and pS40 31P
resonances.Binding of doubly phosphorylated hTH1 peptide
to 14-3-3z
Binding between doubly phosphorylated proteins and 14-3-
3 has previously been characterized using various methods,
including isothermal titration calorimetry and fluorescence
polarization (19,27,28). Although these methods provide
overall binding properties, such as Kd or stoichiometry,
important details for a system involving a homodimer and
two binding motifs on the target are lacking. For example,
answers to the question of how individual phosphorylated
amino acids interact with 14-3-3, and what kind of com-plexes are possible, are still incomplete. 31P NMR is ideally
suited to provide such information, since individual 31P
signals can be monitored throughout the course of titra-
tion experiments between various interacting partners. We
therefore prepared doubly phosphorylated hTH1–50 peptide
(pS19pS40-hTH1–50) and monitored 14-3-3z binding to
this peptide by 31P NMR. Our data reveal that a number
of different bound species are present during the course
of the titration (Fig. 2 A). The spectrum of free
pS19pS40-hTH1–50 (blue spectrum in Fig. 2 A; r ¼ 0) con-
tains two well-separated resonances, at 3.76 p.p.m. and at
4.18 p.p.m. for the phosphorous atoms on pSer19 (pS19free)
and pSer40 (pS40free), respectively. At the end of the titra-
tion (light green trace in Fig. 2 A; r ¼ 5), the pS19pS40-
hTH1–50 peptide is saturated with 14-3-3z, and resonances
at 3.26 p.p.m. and 3.43 p.p.m. for the phosphorous atoms on
pSer19 (pS19bound) and pSer40 (pS40c), respectively, are
observed. The bound resonances are broader than those
of the free peptide, reflecting the slower rotational correla-
tion time of the peptide/14-3-3z complex (molecular mass
~62-67 kDa).
The chemical shift of 3.43 p.p.m. is different from the
completely saturated position (3.26 p.p.m.) obtained with
a peptide that contains only phosphorylated Ser40 (pS40-
hTH1–50, Fig. 1 D), indicating that this bound resonance
position contains a contribution from the free pS40 reso-
nance (due to fast exchange on the chemical shift scale).
This signal, therefore, is designated pS40c, instead of
pS40bound. During the titration, the intensities of both the
pS19free and pS40free resonances decrease to the same de-
gree with increasing 14-3-3z concentration, but only the
bound pS19 31P resonance at 3.26 p.p.m. increases in inten-
sity at the same rate (Fig. 2 A, e.g., red spectrum). The
bound pS40 31P resonance at 3.43 p.p.m. is only visible
for excess 14-3-3z over peptide (e.g., purple, yellow, or-
ange, and light-green spectra). These data suggest that
for excess peptide and little 14-3-3z (r < 1), the phospho-
rous group on Ser19 (strong binder) is the one predomi-
nantly bound by 14-3-3z, and two pS19pS40-hTH1–50
peptides are likely bound by one 14-3-3z dimer. For condi-
tions where 14-3-3z is in excess (r > 1), both phosphorous
groups on a single peptide can be bound by one 14-3-3z
dimer.
The complete binding scenario, considering six possible
complexes for the interaction between doubly phosphory-
lated peptide (free peptide is depicted as 19–40) and 14-
3-3z (free 14-3-3z dimer is depicted as P[[ ), is presented
in Fig. 2 B. Based on this interaction scenario and taking
into account that resonances can be in slow or fast ex-
change on the chemical shift scale (marked by blue and
red arrows, respectively), five different resonances are ex-
pected to be observable in the 31P NMR spectra (see
below). Phosphorous groups that exhibit identical reso-
nance frequencies, thus contributing intensity to the sameBiophysical Journal 107(9) 2185–2194
2190 Hritz et al.peak, are labeled in the same colors in Fig. 2, B and C. The
derived binding scheme is based on two assumptions:
1. The bound 31P chemical shifts of pS19 and pS40 are
identical when saturated with 14-3-3z, irrespective of
whether the second binding site on the 14-3-3z dimer
is occupied or not; and
2. The individual phosphorous resonances in pS19pS40-
hTH1–50 exhibit the same NMR exchange regime as
those for the singly phosphorylated peptides (Fig. 1, B
and D, i.e., the pS19 resonance is in slow exchange
and that of pS40 is in fast exchange on the 31P NMR shift
scale).
Note that the slow or fast exchange regimes apply not only
to the interaction between free peptide (19–40) and the one
site occupied 14-3-3z dimer complex ðP/1940 or P/4019Þ but
also to various additional 14-3-3z complexes (Fig. 2 B). For
example, the pS40 phosphorous resonance of P4019j, the com-
plex in which both sites on the protein dimer engage the two
phosphate groups on 19‒40, is in fast exchange with that of
P/1940, the complex in which one site on the dimer engages
the pS19 phosphate group of the peptide, since very weak
binding of the phosphate group of pS40 is involved. On
the other hand, P4019j and P
/
4019 are in slow exchange, since
the exchange involves tight binding of the phosphate group
of pS19. In agreement with the above binding scheme, five
distinct peaks are observed in the 31P spectra during the
titration (Fig. 2 A).
Multiple complexes contribute to the intensity of each phos-
phorous resonance. All peptides with the pS19 phosphate
group free of 14-3-3z protein (19–40,P/4019;P
4019
1940; P
4019
4019 )
contribute to the peak labeled ‘‘pS19free’’ (19 colored green in
Fig. 2, B and C). Free peptide (19‒40) as well as any pep-
tides bound to 14-3-3z via the pS40 phosphate group
ðP/4019;P40191940; P40194019Þ (40 colored orange in Fig. 2, B and
C) will contribute to the peak labeled ‘‘pS40free’’ in Fig. 2 A.
Given that the same peptide can contribute intensity to two
different resonances (pS19free and pS40free), the total intensity
of the two resonances is expected to be similar, as is indeed
observed in the 31P spectra (Fig. 2 A).
Any complexes of 14-3-3z that contain peptide bound via
the phosphate group on pS19 (P/1940, P
1940
1940, P
40
19
j, and
P40191940; 19 colored blue in Fig. 2, B and C) add intensity
to the peak labeled ‘‘pS19bound.’’ The pS40c peak arises
from the pS40 phosphate groups in the P4019j and P
/
1940 com-
plexes (40 colored purple in Fig. 2, B and C), which are in
fast exchange. The contribution from the free pS40 phos-
phate group in P/1940 causes the ‘‘pS40
c’’ resonance to
slightly shift toward the free position (4.18 p.p.m.) and,
therefore, it is observed at 3.43 p.p.m., slightly downfield
from the bound position (3.26 p.p.m.) of the singly phos-
phorylated pS40 peptide (Fig. 1 D). In contrast, the position
of the pS19bound peak is at 3.27 p.p.m., identical to the
bound position of the singly phosphorylated pS19 peptide
(Fig. 1 B). The reason for this is that the phosphate groupsBiophysical Journal 107(9) 2185–2194that contribute to the pS19bound peak are in slow exchange,
thus no weighted chemical shift averaging comes into play.
Finally, the free pS40 phosphate groups in the P19401940 and
P19404019 complexes (40 colored brown in Fig. 2, B and C), de-
noted pS40*, reside on the peptide that is bound to 14-3-3z
via pS19, but they are not buried in the 14-3-3z binding site
and are free in solution, surrounded by solvent. Note that
pS40* is observed as a distinct peak at 3.93 p.p.m., in
slow exchange with the pS40 phosphate resonance (4.18
p.p.m.) of the free peptide (Fig. 2 A), because the peptides
in these complexes are bound to 14-3-3z via the pS19 phos-
phate group.
The relationships listed in Fig. 2 C imply that the total
normalized area (denoted as ‘‘A’’) of all peaks in Fig. 2 A
corresponds to 2, because the peptide contains two phos-
phate groups:
A

pS19free
þ ApS40freeþ ApS19boundþ AðpS40cÞ
þ AðpS40Þ  cpep ¼ 2½19 40 þ P/4019
þ P/1940þP4019jþ 2P19401940þ 2P19404019
þ 2P40194019 ¼ 2  cpep:
(3)Assignment of phosphorous resonances by
selective thiophosphorylation
The 31P resonance assignment of the pS19 and pS40 in
the pS19pS40-hTH1–50 peptide (Fig. 2 A) was initially
obtained using the assignment of singly phosphorylated
hTH1–50 peptides (Fig. 1, B and D). We confirmed
the assignment using a hTH1–50 peptide that was phos-
phorylated on Ser19 and thiophosphorylated on Ser40
(pS19tpS40-hTH1–50). Thiophosphorylation causes a large
downfield shift of the 31P resonance from ~4.2 p.p.m. (blue
spectra in Fig. 1 D and Fig. 2 A) to 43.95 p.p.m. (blue
spectra in Fig. 3, A and B). Thus, in the spectrum of the
pS19tpS40-hTH1–50 peptide (Fig. 3 B), both resonances
are clearly separated.
A thiophosphate group is assumed to functionally mimic a
phosphate group, given its close chemical structure. To
confirm that no gross changes to 14-3-3z binding were intro-
duced into the system by thiophosphorylation, we carried
out titration experiments with tpS40-hTH1–50 and 14-3-3z
under the same conditions that were used for pS40-hTH1–
50. We determined a Kd value of 3.8 mM for tpS40-hTH1–
50 (Fig. 3 A), compared to 1.0 mM for the pS40-hTH1–50
(Fig. 1D). This demonstrates that binding is slightly reduced
by the replacement of an oxygen atom with a sulfur atom.
Interestingly, binding of 14-3-3z to tpS40-hTH1–50 causes
a downfield 31P chemical shift (Fig. 3 A), whereas binding
to pS40-hTH1–50 induces an upfield shift (see above, and
Fig. 1 D), illustrating that chemical shifts are extremely sen-
sitive to any changes and hard to predict.
Whereas 14-3-3z binding to the pS19pS40-hTH1–50
peptide yields three distinct pS40 phosphorous signals that
AB
FIGURE 3 Binding of thiophosphorylated hTH1–50 peptides to 14-3-3z.
(A) 31P spectra of tpS40-hTH1–50 peptide (0.71 mM) for varying molar ra-
tios of 14-3-3z to the peptide (r); 0:1 (blue), 0.5:1 (red), 1:1 (dark green),
2:1 (purple), 4:1 (orange), and 8:1 (brown). (Inset) The chemical shift
changes upon 14-3-3z binding (Dd) are plotted as a function of molar ratio
(r). (Continuous line) Predicted Dd from fitting the experimental Dd to the
quadratic equation shown in Eq. 2. (B) 31P spectra of pS19tpS40-hTH1–50
(0.83 mM) for varying molar ratios of 14-3-3z to the peptide (r): 0:1 (blue),
0.5:1 (red), 1:1 (dark green), 2:1 (purple), 3:1 (yellow), 4:1 (orange), and
5:1 (light green). To see this figure in color, go online.
Binding of Phospho-TH Peptides to 14-3-3 2191exhibit slow exchange, pS40free, pS40*, and pS40c (Fig. 2 A),
binding to the pS19tpS40-hTH1–50 peptide results in only
two signals that are in fast-intermediate exchange (Fig. 3
B), caused in part by the smaller chemical shift difference be-
tween free (pS40free) and bound (pS40c) resonances (0.60
p.p.m) compared to that for pS19pS40-hTH1–50 (0.94
p.p.m.). However, even with this difference, it seems reason-
able to assume that the binding scheme in Fig. 2 B can be
applied to pS19tpS40-hTH1–50, with Kd2 ¼ 3.8 mM instead
of 1 mM and Keq ¼ 0.26 (see below) rather than 1.5. Using
the well-separated pS19bound 31P resonance in the thiophos-
phorylated peptide (Fig. 3 B) proved beneficial for deconvo-
luting the overlapping pS19 resonances in the 14-3-3z-bound
pS19pS40-hTH1–50 spectra (see Fig. S3).Analysis of the binding equilibrium between
doubly phosphorylated hTH1 peptide to the
14-3-3z homodimer
Fig. 2 B illustrates a comprehensive equilibrium binding sce-
nario for the interaction between the doubly phosphorylated
hTH1 peptide and the 14-3-3z homodimer. Six possible com-
plexes are considered. Because insufficient experimentaldata for the accurate determination of all individual dissoci-
ation constants are available, it is assumed that each subunit
monomer in the 14-3-3z homodimer binds equivalent phos-
phate groups on pS19pS40-hTH1–50 with identical affinity,
irrespective of the state of the other 14-3-3zmonomer, i.e., no
cooperativity is present. Therefore, three independent equi-
librium constants, Kd1, Kd2, and Keq (Fig. 2 B), come into
play. Kd1 (0.15 5 0.03 mM) and Kd2 (1.0 5 0.1 mM) are
the experimentally determined dissociation constants for
the interaction between singly phosphorylated hTH1–50
peptides, pS19-hTH1–50 and pS40-hTH1–50, respectively,
and the 14-3-3z dimer (using the monomer at the concentra-
tion unit); Keq is the equilibrium constant defined by the con-
centration ratio of the ðP4019jÞ complex to the ðP/1940Þ
complex. This is treated as the only variable parameter in
this simplistic equilibrium binding model.
We used three approaches for determining Keq, as follows:
In the first approach, we derived a set of six equations for
the individual, independent equilibria, along with two equa-
tions that are necessary to ensure mass conservation of the
peptide and 14-3-3z (see Fig. S2 A). These equations were
solved numerically in the software MATLAB. The resulting
solutions provide the molar concentration of peptide com-
plexes as a function of the 14-3-3z to doubly phosphorylated
peptide ratio, r (see Fig. S2 B). The equations in Fig. 2 C
link the theoretically predicted molar concentrations of
individual complexes (see Fig. S2 B) with the intensities
of five experimentally observable resonances. By fitting
the theoretical profiles (continuous lines in Fig. 2 D) with
the experimentally observed intensities (individual data
points depicted by x in Fig. 2 D), for several 14-3-3z to pep-
tide molar ratios, r, a Keq value of 1.5 was determined.
In the second approach, the value of Keq could, in princi-
ple, also be determined from the observed difference in the
‘‘pS40c’’ resonance position from that of ‘‘pS40bound,’’ if the
resonance position of pS40 in the P/1940 complex is known.
Unfortunately, this is not known experimentally, but,
assuming that it is identical to that of (pS40*), then the
following equation holds:
dðpS40cÞ ¼

P/1940

dðpS40Þ þ P4019jdðpS40boundÞ
P/1940
þ P4019j : (4)
Considering that  
Keq ¼
P4019j
P/1940
;
then
c 
Keq ¼ dðpS40 Þ  dðpS40 Þ
dðpS40boundÞ  dðpS40cÞ: (5)
If the values of d(pS40*), 3.93 p.p.m.; d(pS40c), 3.43 p.p.m.;
and d(pS40bound), 3.26 p.p.m. are applied to Eq. 5, a Keq
value of 3.0 is found.Biophysical Journal 107(9) 2185–2194
2192 Hritz et al.In the third approach, the value of Keq can be estimated,
based on Kd2 and the local concentration of the pS40 phos-
phate group in the P/1940 complex. In an extended chain
model of the doubly phosphorylated peptide, the distance
between the Ser19 and Ser40 phosphate groups is estimated
to be ~6 nm. The local concentration of the Ser40 phosphate
that resides within a sphere of 6 nm radius, if the Ser19
phosphate from the same peptide is fixed to the first binding
site on the 14-3-3z dimer, would become cloc ~ 1/
(6.022*1023*4*103*(6.109)3)M, i.e., 1.9 mM. Thus, an
estimated value of Keq is

P4019j
	
P/1940
 ¼ cloc=Kd2 ¼ 1:9:
The latter two estimated Keq values of 3.0 and 1.9 are very
similar to the value determined from fitting (Keq ¼1.5),
considering that Keq values of 3.0, 1.9, and 1.5 result in rela-
tive populations of 75, 66, and 60%, respectively, of the P4019j
complex.
Using the simplified binding model (Fig. 2 B), with Kd1¼
0.15 mM, Kd2 ¼ 1.0 mM, and Keq ¼ 1.5, populations of
P/4019, P
1940
4019, and P
4019
4019 complexes were found to be
significantly lower than other complexes (<5.5%; see
Fig. S2 B). For example, at a 1:1 molar ratio of doubly phos-
phorylated peptide to 14-3-3z (r ¼ 1), 37.0% of the peptide
is unbound; 17.7% of the peptide is in the P4019j complex;
11.8% is in P/1940 complex; and 24.1% (2  12.05%) is
in the P19401940 complex. Together, all other species account
for 9.4% of the total population. At r ¼ 5, the theoretical
binding model predicts 52.5% of the peptide is in the P4019j
complex and 35% is in the P/1940 complex. Note that the
31P resonances of the pS40 phosphate groups in these two
complexes are in fast exchange (Fig. 2 B), resulting in a
single pS40c peak (Fig. 2 A).DISCUSSION
In the prevailing model of 14-3-3 binding to doubly phos-
phorylated partners, the partners contain a high affinity,
sometimes called a ‘‘gatekeeper’’ residue, which initially in-
teracts with 14-3-3, and a secondary, weaker epitope, which
only binds when the gatekeeper site is already bound to 14-
3-3 (23). hTH1 that is singly phosphorylated on Ser40 is
thought to be unable to bind 14-3-3z, whereas the pS19
phosphate is the high affinity epitope (18,19). Our NMR re-
sults with the N-terminal 50 residue peptide, pS40-hTH1–
50, indicate, however, that binding of pS40 to 14-3-3z is
indeed possible, as evidenced by the change from the
free peptide phosphorous resonance to the bound one.
This interaction is clearly weaker (Kd ¼ 1.0 5 0.1 mM)
than that between 14-3-3z and pS19-hTH1–50, containing
the purported gatekeeper phosphate, which binds a factor-
of-10 tighter (Kd ¼ 0.155 0.03 mM). Therefore, even un-
der conditions where 14-3-3z is present in excess over theBiophysical Journal 107(9) 2185–2194pS19pS40-hTH1–50 peptide, two complexes, P4019j and
P/1940, form in a 60:40% (Keq ¼ 1.5) ratio, irrespective of
the 14-3-3z concentration. Our results show that it is
possible that multiple complexes for doubly phosphorylated
binding partners of 14-3-3z may exist, even if in the phos-
phorylated full-length hTH1 additional mechanisms may
come into play and alter the relative binding affinities (18).
Indeed, for the full-length pS40-hTH1, the binding to 14-
3-3g was almost undetectable by native mass spectroscopy
and surface plasmon resonance, while for the doubly phos-
phorylated enzyme Ser40 is involved in binding to 14-3-3g
(22). In addition, binding of one 14-3-3g dimer to one of
the monomers in tetrameric hTH1—which is organized as
a dimer of dimers—appears to interfere with the binding
of an additional 14-3-3g dimer to the adjacent monomer
in hTH1, but not to the dimer at the opposite end, as seen
in electron micrographs of the complex (22). Thus, in the
complex involving the full-length enzyme, steric factors
appear to be responsible for moving the equilibrium toward
a scenario where the pS19 site binds to a single monomer
in the 14-3-3 dimer. Whether this is the case for all 14-3-3
interactions with phosphorylated regulatory regions is un-
clear. In general, the presence of additional interactions
and their contributions to the overall regulatory mechanisms
have to be ascertained and confirmed for each individual
system.
At this point, it may be of interest to analyze the underly-
ing thermodynamics that govern the observed interaction
between 14-3-3z and pS19pS40-hTH1–50 (or other similar
peptides, denoted as 1‒2, with two phosphorous sites), with
the P21j bound form as the dominant complex when 14-3-3z
is in excess and P1212 dominant when peptide is in excess.
For simplicity, we assume that the binding of site 1 (primary
site) is independent of that of site 2 (secondary site) and that
peptide binding to one binding site on the 14-3-3z dimer
leads to a global entropy decrease (DSG < 0), whereas
engagement of the second site on the same peptide only re-
sults in a local entropy decrease (DSL < 0). The enthalpy
changes corresponding to the binding of the primary and
secondary sites to 14-3-3 protein are denoted as DH1 and
DH2. Given these assumptions, the condition where the
amount of P1212 is larger than P
2
1
j (when peptide is in excess
over 14-3-3z; r < 1), i.e.,
DG

P1212
 DGP21j<0;
results inDH1  DH2<TðDSG  DSLÞ: (6)
The opposite inequality
ðDH1  DH2>TðDSG  DSLÞÞ
is expected for the case when the amount of P21j is larger than
12P12 (when r > 1). In the case that the two phosphorous
Binding of Phospho-TH Peptides to 14-3-3 2193groups exhibit comparable binding affinities (e.g., such is
the case for the PKCε-V3 peptide that contains tandem
repeat sequences (27)),
DG

P21j
 DGP1212 ¼ ðDH2  DH1Þ þ TðDSG  DSLÞ:
Because DH1  DH2 ~ 0 and T(DSG  DSL) < 0, the free
energy difference

DG

P21j
 DGP1212
becomes negative, making the amount of P21j complex larger
than the amount of P1212 complex, irrespective of the r value.
Considering the large number of 14-3-3 binding partners
and the above-described different binding modes, both cases
are thermodynamically possible and may contribute to the
regulation imparted by 14-3-3 on its targets.CONCLUSIONS
A detailed analysis of the interaction between singly or
doubly phosphorylated hTH1–50 peptides and 14-3-3z is
presented. Using phosphorous NMR, dissociation constants
for the binding of singly phosphorylated peptides, pS19-
hTH1–50 and pS40-hTH1–50, to 14-3-3z were determined.
They differ by a factor of 10, with the Ser19 phosphorylated
peptide exhibiting a higher affinity (Kd ¼ 0.15 5 0.03 vs.
1.0 5 0.1 mM). Furthermore, for the doubly phosphory-
lated peptide, pS19pS40-hTH1–50, a mixture of distinct
complexes was observed, which permitted us to derive a
comprehensive equilibrium binding scheme. All six
possible different complexes are taken into account, and
the system is described by three equilibrium constants:
Kd1 ¼ 0.15 mM, Kd2 ¼ 1.0 mM, and Keq ¼ 1.5. For excess
pS19pS40-hTH1–50 peptide, the major complex is the 14-
3-3z dimer with two peptides bound via the phosphate group
on Ser19 ðP19401940Þ, whereas, for excess 14-3-3z, two major
complexes are seen, each one with a doubly phosphorylated
peptide bound to one 14-3-3z dimer, with the Ser19 phos-
phate group bound to one 14-3-3z subunit, and the Ser40
phosphate group either bound to the second subunit ðP4019jÞ
or free in solution ðP/1940Þ in a 60:40 ratio.
For other systems, the underlying thermodynamics will
contribute to whether a doubly phosphorylated partner
will bind with a 1:1 stoichiometry to the 14-3-3z dimer or
if a mixture of complexes is formed. It is likely that most
14-3-3z binding partners will possess phosphorylated resi-
dues that exhibit different affinities for the binding sites
on 14-3-3z. The presented methodology derived by moni-
toring individual 31P resonances has general applicability
for any complex system involving 14-3-3 and doubly phos-
phorylated ligands, and it will be interesting to extend this
approach to full-length hTH1 or other target proteins.SUPPORTING MATERIAL
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